Drug development

#Drug development #Drug discovery #Genetics / genomics #Mass spectrometry / NMR

The path to improved safety of gene-based products

Listen to this article on the DDW Podcast: Kerstin Pohl, Senior Global Marketing Manager, Gene Therapy & Nucleic Acid at SCIEX, looks at the application of liquid chromatography-mass spectrometry for analysing host cell proteins. Gene-based therapeutics and vaccines hold immense potential for more efficient and personalised treatment and prevention of complex… Read More

#Exclusive Content

#Animal models #Animal testing #Assays #Drug development #Drug discovery #Mouse models

Accelerating NDA filing through faster carcinogenicity assessment

Dr Megan MacBride and Dr Caroline Horizny Mitchell, Taconic, examine recent changes to animal testing in drug design. Drug discovery and development is an arduous process that can cost upwards of $2.6 billion and take over 10 years. While the discovery phase – which includes target discovery, target validation, lead… Read More

#Exclusive Content

#Drug development #Drug discovery #Immuno-oncology #Immunomodulators #Immunotherapy #Oncology

Podcast: Keep up to date with DDW Highlights

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  DDW’s Diana Spencer has selected five stand-out news headlines this week, which all relate to immunotherapy… Read More

#News

#Drug development #Drug discovery #Immuno-oncology #Immunomodulators #Immunotherapy #Oncology

This week in drug discovery (1-5 May)

News round-up for 1-5 May by DDW Digital Content Editor Diana Spencer. My five stand-out news headlines this week all relate to immunotherapy or immunomodulatory therapies for cancer, particularly advances in our understanding of how other factors in the body, i.e., vitamin D levels and the… Read More

#News

Adcendo Lab
#Antibodies #Antibody drug conjugate (ADC) #Biotech #Drug development #Seed funding

Financing ensures development of Adcendo’s ADC asset 

Adcendo, a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of cancers with a high unmet medical need, has completed a successful Series A extension financing round, raising a further €31 million, following the €51 million Series A financing in April 2021. Read More

#News

Cancer cell
#Cancer #Drug development #Oncology #Pharma

Scientific Affairs Group expands to over 200 oncologists  

Drug development company Ellipses Pharma now has more than 200 oncology experts from 106 institutions worldwide providing analysis and advice on selection of the most promising potential cancer medicines in its Scientific Affairs Group (SAG).   The number of experts joining the SAG has increased by 53% in… Read More

#News

#Anxiety disorder #Diabetes #Drug development #Drug discovery #Geographic atrophy #HIV #Lung cancer #Oncology

Podcast: This week’s drug discovery highlights

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Each of our top five stories this week exemplify the scientific curiosity that fuels the drug… Read More

#News

#Drug development #Drug discovery #Emulate #Organ-on-a-chip

An introduction to organ-on-a-chip technology

Download Emulate’s Introduction to Organ-on-a-Chip Technology eBook to learn about: What Organ-Chips are, how they work, and why they are transforming the way drugs are discovered and developed How Organ-Chips overcome the main challenges of conventional in vivo and in vitro models The wide variety of insights and endpoint analyses… Read More

#Resources

#Drug development #Drug discovery #eBook #Emulate #Organ-on-a-chip

eBook: An introduction to organ-on-a-chip technology

Download Emulate’s Introduction to Organ-on-a-Chip Technology eBook to learn about: What Organ-Chips are, how they work, and why they are transforming the way drugs are discovered and developed How Organ-Chips overcome the main challenges of conventional in vivo and in vitro models The wide variety of insights… Read More

#News

#Anxiety disorder #Diabetes #Drug development #Drug discovery #Geographic atrophy #HIV #Lung cancer #Oncology

This week in drug discovery (24-28 April)

News round-up for 24-28 April by DDW Digital Content Editor Diana Spencer. Each of our top five stories this week exemplify the scientific curiosity that fuels the drug discovery sector, ultimately leading to better treatments for patients. The stories cover the efforts by research teams to… Read More

#News

Antibody drug conjugate
#AI / data analytics / healthtech / informatics #Antibodies #Antibody drug conjugate (ADC) #Big pharma #Drug development #Precision medicine

A personal view on antibody drug development

Oliver Schon, PhD, is VP Research & Development at BiVictriX Therapeutics, a UK-based emerging drug discovery and development company generating a pioneering first-in-class next-generation ADC anti-cancer therapeutics which exhibit superior selectivity towards cancer. Dr Schon is applying his broad expertise from lead discovery to manufacture in order to progress differentiated,… Read More

#Exclusive Content

Organ on a chip
#CN Bio #Drug development #Drug screening #In vivo #Organ-on-a-chip #Organoids #SLAS

Organ-on-a-chip models in drug development

This paid-for advertorial by CN Bio appeared in DDW Volume 24 – Issue 2, Spring 2023 Despite advancements, the drug development process remains inefficient. Even with rigorous optimisation and validation, we face a 90% failure rate by the clinical phase1. Existing in vivo and in vitro models aren’t up to… Read More

#Exclusive Content

#Cell culture #Drug development #Drug discovery #Guide #iPSC

New Guide: How to get the best out of your neurons

A new Guide is now available entitled ‘Four cell culture hacks to get the best out of your neurons’, sponsored by bit.bio. Make your iPSC-derived glutamatergic neuron cultures a success every time with these tips from a neuronal cell culture expert. Download the Guide to learn: How to prevent glutamatergic… Read More

#News

#Cell culture #Drug development #Drug discovery #Guide #iPSC

Four cell culture hacks to get the best out of your neurons

Make your iPSC-derived glutamatergic neuron cultures a success every time with these tips from a neuronal cell culture expert. In this Guide, you will learn: How to prevent glutamatergic neurons from detaching from culture surfaces How to formulate extracellular matrix coatings to promote cell adherence The best timings for media… Read More

#Intelligence #Resources

World Parkinson's Day
#Drug development #Drug discovery #Neurodegenerative disorders #Parkinson's

World Parkinson’s Day: New drug research

It is World Parkinson’s Day (11 April), raising awareness of the fastest growing neurological condition in the world. There is currently no cure, and although there are therapeutics to manage the symptoms, these usually bring side-effects, and so there is still need for new therapeutic options. Here, we take a… Read More

#Exclusive Content #Trending News

#AACR #Cancer research #Drug development #Drug discovery #Events

Looking ahead to AACR  

Ahead of attending the American Association for Cancer Research (AACR) annual meeting from 14-19 April, 2023 at the Orange County Convention Center in Orlando, Florida, DDW’s Megan Thomas outlines what to expect from the event.   Programme highlights   The topic tracks include everything from clinical trials, drug development, immunology and bioinformatics,… Read More

#Cancer Research #Exclusive Content